DEFINITIVE PROXY STATEMENT

Company

Actinium Pharmaceuticals, Inc.

Filed

November 18, 2016

Period of Report

December 21, 2016

Accession Number

0001213900-16-018732

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →